SOPHiA GENETICS SA
SOPH
$-0.02
Change (1 day)
$7.37
Year High
$2.70
Year Low
Categories
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
P/E ratio for SOPHiA GENETICS SA (SOPH)
P/E ratio as of 2023: -3.86
According to SOPHiA GENETICS SA's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.86. At the end of 2022 the company had a P/E ratio of -1.51.
P/E ratio history for SOPHiA GENETICS SA from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -3.86 |
| 2022 | -1.51 |
| 2021 | -12.22 |
| 2020 | -27.21 |
| 2019 | -31.67 |
| 2018 | 0.00 |